Weight-loss drugs under review in UK after reports of suicidal thoughts

Ozempic and Saxenda among drugs being reviewed after reports of suspected adverse reactions in patients

A popular weight-loss drug is among those being reviewed in the UK after being linked to reports of suicidal or self-harming thoughts within patients.

Reuters reports that the Medicines and Healthcare Products Regulatory Agency (MHRA) said in the statement that it was reviewing a class of drugs known as GLP-1 receptor agonists, sold by the company Novo Nordisk.

In the UK and Ireland, Samaritans can be contacted on freephone 116 123, or email jo@samaritans.org or jo@samaritans.ie. In the US, you can call or text the National Suicide Prevention Lifeline on 988, chat on 988lifeline.org, or text HOME to 741741 to connect with a crisis counselor. In Australia, the crisis support service Lifeline is 13 11 14. Other international helplines can be found at befrienders.org